Reports

The global Horseradish Peroxidase (HRP) market was valued at 54.9 million in 2024 and is projected to reach US$ 93 million by 2031, at a CAGR of 8.0% during the forecast period.

The global Immobilized Trypsin market was valued at 9.7 million in 2024 and is projected to reach US$ 14.5 million by 2031, at a CAGR of 6.1% during the forecast period.

The global Recombinant Trypsin market was valued at 29.8 million in 2024 and is projected to reach US$ 53.4 million by 2031, at a CAGR of 8.9% during the forecast period.

The global Pregnant Vitamin And Supplements market was valued at 1152 million in 2024 and is projected to reach US$ 1845 million by 2031, at a CAGR of 7.1% during the forecast period.

The global Gene Sequencing market was valued at 15790 million in 2024 and is projected to reach US$ 53280 million by 2031, at a CAGR of 19.4% during the forecast period.

The global Lipid Contract Manufacturing market was valued at 759 million in 2024 and is projected to reach US$ 706 million by 2031, at a CAGR of -1.1% during the forecast period.

The global Specialty Cell Culture Media market was valued at 1967 million in 2024 and is projected to reach US$ 3999 million by 2031, at a CAGR of 10.9% during the forecast period.

The global Follicular Lymphoma Drugs market was valued at 1688 million in 2024 and is projected to reach US$ 2859 million by 2031, at a CAGR of 8.0% during the forecast period.